Patent Baristas

We’re seeing more interest in patenting of micro- and nanotechnology inventions. Red Herring recently ran an interesting article describing a report by Lux Research entitled “The Nanotech Intellectual Property Landscape,” showing that, as of March, there were 3,818 nanotechnology patents issued by the USPTO with 1,777 more pending. The report describes a “crowded and entangled […]

The next edition of Blawg Review is up at Law & Entrepreneurship News. Law & Entrepreneurship News is a collaborative project involving Professor Gordon Smith and students at the University of Wisconsin Law School. Law & Entrepreneurship News provides a nice collection of information particularly of interest to small businesses and emerging growth companies. The […]

As a Monday morning patent litigation round-up of interesting proceedings, I put together a list of recent actions. You just can’t tell the players without a program: Eli Lilly has filed a lawsuit to block Teva Pharmaceuticals from selling generic Symbyax after Teva filed for an Abbreviated New Drug Application (ANDA) for generic Symbyax on […]

The Motley Fool offered the “Lowdown on Patent Shakedowns” and talked about the rise of the patent terrorists in a recent article. It seems that the rhetoric has really ratcheted up a notch recently – there must be some intense lobbying going on. The term patent terrorists (or the more polite, patent trolls) has been […]

The Washinton Times reported that a so-called wild-card patent provision, expected to be proposed to Congress as part of the Bioshield II bill (Senate Bill S.3, Protecting America in the War on Terror Act of 2005), has been modified to overcome objections from companies that manufacture generic drugs. S.3 would make changes to the earlier […]

In what may be a sign that blogs have jumped-the-shark, the current issue of BusinessWeek has a cover story emblazoned with large letters that “Blogs Will Change Your Business. Look past the yakkers, hobbyists, and political mobs. Your customers and rivals are figuring blogs out. Our advice: Catch up…or catch you later.” They cite some […]

Merck & Co. announced it intends to file an appeal with the U.S. Supreme Court asking to overturn the ruling that the patent on its blockbuster osteoporosis drug Fosamax will expire a decade earlier than expected. The U.S. Court of Appeals for the Federal Circuit rejected a Merck & Co. request to reconsider a decision […]

At the WIPO General Assembly meetings from September 27 to October 5, 2004 the governments of Argentina and Brazil submitted a proposal for “the Establishment of a Development Agenda for WIPO”. The proposal was co-sponsored by Bolivia, Cuba, Dominican Republic, Ecuador, Egypt, Iran, Kenya, Peru, Sierra Leone, South Africa, Tanzania and Venezuela. The Development Agenda […]